SCP
ROIV icon

Sender Company & Partners’s Roivant Sciences ROIV Stock Holding History

Sender Company & Partners’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-64,973
Closed -$732K – 569
2025
Q2 		$732K Buy
+64,973
New +$704K 0.21% 115

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Sender Company & Partners's ROIV Position: Q3 2025 in Review

Sender Company & Partners sold out of Roivant Sciences (ROIV) in Q3 2025, closing a stake of 64,973 shares — an estimated $732K sold.

Sender Company & Partners first reported a position in ROIV in Q2 2025 and held it in 1 quarter. The position peaked at $732K in Q2 2025. 337 funds tracked by Wall St. Rank hold ROIV as of Q3 2025.

  • Sender Company & Partners reported no remaining Roivant Sciences position as of Q3 2025 after selling out during the quarter.
  • Sender Company & Partners sold 64,973 Roivant Sciences shares in Q3 2025, an estimated $732K.
  • Sender Company & Partners first reported a position in Roivant Sciences in Q2 2025 and held it in 1 quarter.
  • Sender Company & Partners's Roivant Sciences position peaked at $732K in Q2 2025.
  • 337 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2025.

Based on Sender Company & Partners's 13F filing for Q3 2025, filed 17 Nov 2025.